EP3165539
IL-17 viðtaka A mótefnavakabindandi prótín
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.10.2007EP published:
8.12.2021EP application number:
16190586.4
EP translation filed:
24.2.2022Grant published:
15.3.2022EPO information:
European Patent Register
Max expiry date:
30.9.2027Expiry date:
30.9.2025Next due date:
30.10.2025
Title in English:
IL-17 RECEPTOR A ANTIGEN BINDING PROTEINSLanguage of the patent:
English
Timeline
Today
1.10.2007EP application
8.12.2021EP Publication
24.2.2022Translation submitted
15.3.2022Registration published
30.9.2025Expires
Owner
Name:
Amgen K-A, Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Inventor
Name:
TOCKER, JoelAddress:
Issaquah, WA 98029, US
Name:
PESCHON, Jacques J.Address:
Seattle, WA 98105, US
Name:
LIM, Ai ChingAddress:
Mercer Island, WA 98040, US
Name:
MEHLIN, ChristopherAddress:
Seattle, WA 98107, US
Name:
FITZPATRICK, DavidAddress:
Karana Downs, Queensland 4306, AU
Name:
SMOTHERS, James F.Address:
Quincy, MA 02169, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
827882 PDate:
2.10.2006Country:
US
Number:
873072 PDate:
5.12.2006Country:
US
Number:
969895 PDate:
4.9.2007Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 37/02
Annual fees
Number
Paid
Expires
Payer
Number: 16
Paid: 27.9.2022
Expires: 30.9.2023
Payer: Zacco Denmark A/S
Number: 17
Paid: 7.9.2023
Expires: 30.9.2024
Payer: Zacco Denmark A/S
Number: 18
Paid: 24.9.2024
Expires: 30.9.2025
Payer: Zacco Denmark A/S